Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:49 AM
Ignite Modification Date:
2025-12-25 @ 2:49 AM
NCT ID:
NCT02727933
Eligibility Criteria:
Inclusion Criteria:
* Patients with CHC genotype 1b and compensated liver disease, including cirrhotic patients
* Eligible for treatment with Daklinza and Sunvepra as indicated in the locally approved prescribing information.
Exclusion Criteria:
* Off-label use of Daklinza and Sunvepra
* Patients with a contraindication for the use of Daklinza and Sunvepra as described in the locally approved prescribing information
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
19 Years
Study:
NCT02727933
Study Brief:
Protocol Section:
NCT02727933